Pipeline
Our pipeline
Diversified candidates with great potential
Our platform technologies can be used to discover and modify various biologics and applied to a wide range of disease areas. If you are interested in discussing partnerships using our platforms or on the below assets, please contact us.
| ID | Target indicationID | Phase | Technology | ||||
|---|---|---|---|---|---|---|---|
| Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
| GT-02037 | Acromegaly | now | Glycosylation | ||||
| GT-15019 | Multiple sclerosis | now | Glycosylation | ||||
| GT-11322 | Alzheimer’s | now | Nose-to-Brain | ||||
| GT-11474 | Treatment-resistant depression |
now | Nose-to-Brain | ||||